SCHEMBL3264986

SCHEMBL3264986

Cc1[nH]c2c(C)cccc2c1CC(N)=O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.75
KMT2A Q03164 4/20 0.75
KDM4E B2RXH2 3/20 0.75
MEN1 O00255 3/20 0.75
GAA P10253 2/20 0.75
EGFR P00533 1/20 0.51
AHR P35869 1/20 0.50
TSHR P16473 2/20 0.48
POLB P06746 2/20 0.48
HPGD P15428 2/20 0.48
LMNA P02545 1/20 0.48
ALDH1A1 P00352 3/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
CASP1 P29466 1/20 0.45
CASP7 P55210 1/20 0.45
RPA1 P27694 1/20 0.42
MCL1 Q07820 1/20 0.42
ATM Q13315 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6291031 0.86 MAPT (1.00) MAPTKMT2AKDM4EMEN1GAA
SCHEMBL3636076 0.85 KDM4E (0.55) MAPTKMT2AKDM4EMEN1GAA
SCHEMBL3382868 0.85 KDM4E (0.55) MAPTKMT2AKDM4EMEN1GAA
SCHEMBL3383227 0.85 MAPT (0.55) MAPTKMT2AKDM4EMEN1GAA
SCHEMBL3382448 0.81 SMN1; SMN2 (0.64) MAPTKMT2AKDM4EMEN1GAA
SCHEMBL20120113 0.80 KDM4E (0.73) MAPTKMT2AKDM4EMEN1GAA
SCHEMBL4744827 0.78 CYP1A2 (0.73) MAPTKMT2AKDM4EMEN1GAA
SCHEMBL3382621 0.78 ALDH1A1 (0.73) MAPTKMT2AKDM4EMEN1GAA
SCHEMBL30254999 0.78 ALDH1A1 (0.73) MAPTKMT2AKDM4EMEN1GAA
SCHEMBL19871249 0.77 MAPT (0.63) MAPTKMT2AKDM4EMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010012397-A1 N-(INDOL-3-YLALKYL)(HETERO)ARYLAMIDE DERIVATIVES AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 WO claimed
EP-2149551-A1 N-(indol-3-ylalkyl)-(hetero)arylamid derivatives as modulators of EP2 receptors Bayer Schering Pharma AG (DE) 2010-02-03 EP claimed